Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
confirmed increased small nerve fibre abundance in both skin and cornea Sarcoidosis-associated small fibre neuropathy Phase 2 RCT confirmed ARA-290 produced relief of neuropathy-related symptoms in sarcoidosis patients with moderate-to-severe neuropathic pain, with approximately 50% response rate versus placebo
Versus near-zero through intact skin under identical conditions 3
On December 18, 2025, Novo Nordisk submitted a New Drug Application to the FDA, with review expected in 2026
This includes tendons, ligaments, muscles, bones, and joints
Lupus in Men On the contrary, men represent less than a quarter of lupus patients
Implications for apoptosis
US$ 24.35
US$ 20.67
US$ 20.23
US$ 22.08
